Medable Allies with MRN to Support New Remote Care Capabilities and Continued Research During COVID-19
Medable Inc.and MRN announced a global alliance to bring shared capabilities to decentralized clinical trials. Medable will empower MRN’s home clinical trial specialists to conduct home and remote visits using Medable’s Trial-Fit Telemedicine. The app can be deployed in one week or less for use in existing trials. These capabilities are especially important for clinical trial continuity in spite of widespread shelter-in-place initiatives due to COVID-19.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025